drugset / Trial / NCT00003907
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Phase 2
Completed
50 enrolled
Eastern Cooperative Oncology Group
National Cancer Institute (NCI) · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow to the tumor and keeping chemotherapy drugs near the tumor. PURPOSE: Phase II trial to study the effectiveness of chemoembolization in treating patients who have primary liver cancer or metastases to the liver that cannot be surgically removed.
Timeline
- Start
- 1999-12-15
- Primary completion
- 2011-05
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 100 mg | Other |
| Subject | Doxorubicin | Other / unclassified | 30 mg | Other |
| Subject | Mitomycin C | Other / unclassified | 30 mg | Other |